These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22475514)

  • 1. Multimerization improves targeting of peptide radio-pharmaceuticals.
    Carlucci G; Ananias HJ; Yu Z; Van de Wiele C; Dierckx RA; de Jong IJ; Elsinga PH
    Curr Pharm Des; 2012; 18(17):2501-16. PubMed ID: 22475514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hitting multiple targets with multimeric ligands.
    Handl HL; Vagner J; Han H; Mash E; Hruby VJ; Gillies RJ
    Expert Opin Ther Targets; 2004 Dec; 8(6):565-86. PubMed ID: 15584863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rigid linkers for bioactive peptides.
    Vagner J; Handl HL; Monguchi Y; Jana U; Begay LJ; Mash EA; Hruby VJ; Gillies RJ
    Bioconjug Chem; 2006; 17(6):1545-50. PubMed ID: 17105235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.
    Carlucci G; Ananias HJ; Yu Z; Hoving HD; Helfrich W; Dierckx RA; Liu S; de Jong IJ; Elsinga PH
    Mol Pharm; 2013 May; 10(5):1716-24. PubMed ID: 23590837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new bifunctional chelator for copper radiopharmaceuticals: a cage amine ligand with a carboxylate functional group for conjugation to peptides.
    Ma MT; Karas JA; White JM; Scanlon D; Donnelly PS
    Chem Commun (Camb); 2009 Jun; (22):3237-9. PubMed ID: 19587925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-targeted diagnostics and radiotherapeutics.
    Tweedle MF
    Acc Chem Res; 2009 Jul; 42(7):958-68. PubMed ID: 19552403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.
    Lindner S; Michler C; Wängler B; Bartenstein P; Fischer G; Schirrmacher R; Wängler C
    Bioconjug Chem; 2014 Mar; 25(3):489-500. PubMed ID: 24533789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors.
    Cowell SM; Balse-Srinivasan PM; Ahn JM; Hruby VJ
    Methods Enzymol; 2002; 343():49-72. PubMed ID: 11665587
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivalent ligand: design principle for targeted therapeutic delivery approach.
    Chittasupho C
    Ther Deliv; 2012 Oct; 3(10):1171-87. PubMed ID: 23116010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression.
    Nomura W; Koseki T; Ohashi N; Mizuguchi T; Tamamura H
    Org Biomol Chem; 2015 Aug; 13(32):8734-9. PubMed ID: 26186480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoradiotherapy with peptides - status and future development.
    Haberkorn U; Eisenhut M; Altmann A; Mier W
    Curr Med Chem; 2008; 15(3):219-34. PubMed ID: 18288982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing allosteric peptide ligands targeting a globular protein.
    Selz KA; Samoylova TI; Samoylov AM; Vodyanoy VJ; Mandell AJ
    Biopolymers; 2007 Jan; 85(1):38-59. PubMed ID: 17009317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin.
    Kitov PI; Shimizu H; Homans SW; Bundle DR
    J Am Chem Soc; 2003 Mar; 125(11):3284-94. PubMed ID: 12630884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family.
    Nissen KB; Haugaard-Kedström LM; Wilbek TS; Nielsen LS; Åberg E; Kristensen AS; Bach A; Jemth P; Strømgaard K
    PLoS One; 2015; 10(2):e0117668. PubMed ID: 25658767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.
    Notni J; Šimeček J; Wester HJ
    ChemMedChem; 2014 Jun; 9(6):1107-15. PubMed ID: 24700633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals.
    Müller C; Farkas R; Borgna F; Schmid RM; Benešová M; Schibli R
    Bioconjug Chem; 2017 Sep; 28(9):2372-2383. PubMed ID: 28898054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.
    Tornesello AL; Tornesello ML; Buonaguro FM
    Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.